Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Operating Expenses: 2011-2024

Historic Operating Expenses for Veracyte (VCYT) over the last 14 years, with Dec 2024 value amounting to $282.0 million.

  • Veracyte's Operating Expenses rose 2.00% to $68.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $314.6 million, marking a year-over-year increase of 2.22%. This contributed to the annual value of $282.0 million for FY2024, which is 10.61% down from last year.
  • According to the latest figures from FY2024, Veracyte's Operating Expenses is $282.0 million, which was down 10.61% from $315.5 million recorded in FY2023.
  • Over the past 5 years, Veracyte's Operating Expenses peaked at $315.5 million during FY2023, and registered a low of $152.9 million during FY2020.
  • For the 3-year period, Veracyte's Operating Expenses averaged around $271.4 million, with its median value being $282.0 million (2024).
  • Per our database at Business Quant, Veracyte's Operating Expenses spiked by 97.17% in 2021 and then declined by 28.09% in 2022.
  • Veracyte's Operating Expenses (Yearly) stood at $152.9 million in 2020, then surged by 97.17% to $301.4 million in 2021, then decreased by 28.09% to $216.8 million in 2022, then soared by 45.54% to $315.5 million in 2023, then fell by 10.61% to $282.0 million in 2024.